Mupirocin Infectopharm

Mupirocin, the active ingredient in Mupirocin Infectopharm, is an antibiotic presented as a 2% ointment for nasal use. It is employed to eradicate nasal carriage of Staphylococcus aureus, including methicillin‑resistant strains, and to help prevent postoperative infections in at‑risk patients.

GNH USA supplies Mupirocin Infectopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable delivery to healthcare facilities across multiple regions.

Mupirocin is used in the management of bacterial colonisation and infection of the nasal passages.

- Nasal decolonisation of Staphylococcus aureus (including MRSA): reduces nasal carriage to lower the risk of subsequent infection. - Prevention of postoperative infections: applied pre‑operatively to decrease surgical site infection rates.

Mupirocin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Itching or mild pruritus at the application site. - Dryness or crusting of the nasal mucosa. - Mild headache.

Serious or Rare Side Effects: - Allergic contact dermatitis with erythema and swelling. - Anaphylactic reaction presenting with respiratory distress. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Mupirocin Infectopharm, consider the following safety measures.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: caution advised; assess risk versus benefit. - Hypersensitivity: avoid if known allergy to mupirocin or formulation components. - Pediatric use: follow prescriber guidance for children. - Concurrent topical antibiotics: monitor for potential resistance development. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mupirocin may interact with other medications; review the following categories.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics of the same class may increase resistance risk. - Systemic antibiotics that share the same bacterial targets can reduce mupirocin efficacy.

Moderate Interactions (Monitor Closely): - Use with immunosuppressive agents may heighten infection risk. - Co‑administration with other nasal sprays may affect local absorption. - Combination with antiseptic nasal preparations may cause increased irritation.